Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Kvaternik Herbert |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Plhak, E; Kvaternik, H; Aigner, RM; Gößnitzer, E Labelling and Quality Control of [131I]MIBG in the Clinical Setting
15th Pharma DocDay ; JUL 4, 2022; Institute of Pharmaceutical Sciences, University of Graz . 2022. [Oral Communication]

 

Kvaternik, H; Plhak, E; Paul, D; Rumpf, B; Aigner, R Ge-68/Ga-68-generator: a radionuclide source or an approved drug?
NUCL MED BIOL. 2021; 96-97: S100-S100.-eSRS Virtual Meeting ; MAY 17-18, 2021; Fredericksburg, TX, USA. [Onlinepräsentation]
Web of Science

 

Plhak, E; Kvaternik, A; Aigner, R; Kvaternik, H Automated synthesis of 16-[I-131]iodohexadecanoic acid: a lymphatic leakage tracer
NUCL MED BIOL. 2021; 96-97: S59-S60.-eSRS Virtual Meeting; MAY 17-19, 2021; Fredericksburg, TX 78624-4576 USA. [Onlinepräsentation]
Web of Science

 

Plhak, E; Pichler, C; Goessnitzer, E; Aigner, RM; Kvaternik, H Development of in-House Synthesis and Quality Control of [Tc-99m]Tc-PSMA-I&S
EUR J NUCL MED MOL I. 2021; 48(SUPPL 1):S224-S224.-34th Annual Congress of the European Association of Nuclear Medicine ; 20- 23 Oct, 2021 ; Vienna, Austria. [Oral Communication]
Web of Science

 

Pernthaler, B; Kulnik, R; Gstettner, C; Kvaternik, H; Aigner, RM 18F-Fluciclovine und 68Ga-PSMA-11 PET/CT in der Rezidivdiagnostik beim Prostatakarzinom.
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin. 2020; -58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin; Jul 7-9, 2020; Leipzig. [Onlinepräsentation]

 

Plhak, E; Gößnitzer, E; Aigner, RM; Kvaternik, H Automatic Synthesis of [*I]β-CIT by radioiododestannylation.
CAFACHEM 2020, Summer School of Organic & Halogen Radiochemistry . 2020; -CAFACHEM 2020; AUG 26 - 28, 2020; London, United Kingdom .
FullText

 

Plhak, E; Kvaternik, H; Aigner, RM; Gößnitzer, E Automatic Synthesis of [*I]β-CIT by radioiododestannylation.
13th Pharma DocDay; Oct 1st, 2020; University of Graz. 2020. [Oral Communication]

 

Plhak,E; Kvaternik, H; Paul, D; Rumpf, B; Aigner, RM Synthesis of [68Ga]Ga-DOTA-NOC: First experiences with the simultaneous automated use of two Galli Ad Generators.
34th International Austrian Winter Symposium – Radionuclides in Molecular Imaging and Therapie; JAN 22-25, 2020; Zell am See. 2020. [Oral Communication]

 

Pernthaler, B; Kvaternik, H; Kulnik, R; Gstettner, C; Aigner, RM Prospective intra-patient comparison of F-18-Fluciclovine and Ga-68-PSMA-11 PET/CT in biochemical recurrence of prostate cancer after definitive therapy
EUR J NUCL MED MOL I. 2019; 46(SUPPL 1):S24-S24.-32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 12-16, 2019; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Pernthaler, B; Kvaternik, H; Kulnik, R; Gstettner, C; Aigner, RM Prospective intra-patient comparison of 18F-Fluciclovine and 68Ga-PSMA-11 PET/CT in biochemical recurrence of prostate cancer after definitive therapy
Eur J Nucl Med Mol Imaging (2019) 46 (Suppl 1): S1–S952. 2019; 46: 24-24.-EANM 2019, Annual Congress of the European Association of Nuclear Medicine; October 12 – 16, 2019; Barcelona, SPAIN. [Oral Communication]
FullText

 

Kvaternik, H; Plhak, E;Rumpf, B; Hausberger, D;Aigner RM. Assay of Bacterial Endotoxins in Radiopharmaceuticals by Microplate Reader
EJNMMI Radiopharmacy and Chemistry. 2018; 3 (Suppl 1): 7--19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR’18); 05-08 April 2018; Groningen, Netherlands. [Poster]

 

Plhak, E; Kvaternik, H; Aigner, RM New Ways to Test the Impurity Tl-201(III)Cl-3 in Thallous(Tl-201) chloride Injection
EUR J NUCL MED MOL I. 2018; 45: S273-S274.-31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 13-17, 2018; Dusseldorf, GERMANY. [Oral Communication]
Web of Science

 

Kvaternik, H; Stanzel, S; Aigner, RM Preparation of 131I-iodohexadecanoic acid: a tracer to localize lymphatic leakage lesions.
Eur J Nucl Med Mol Imaging. 2017; 44 (Suppl2): S534--30th Annual Congress of the European Association of Nuclear Medicine; OCT 21-25; Vienna, AUSTRIA. [Poster]

 

Kvaternik,H; Rumpf BJ; Hausberger,D; Aigner RM Routine determination of HEPES in Ga-68- DOTANOC and Ga-68-PSMA-11 by HPLC
Nuklearmedizin. 2017; 56(2):A80--NuklearMedizin 2017; APR 26-29, 2017; Dresden. [Poster]

 

Stanzel S; Kvaternik H; Pfurtscheller, K; Ulreich, R; Aigner, RM Central Conducting Lymphatic Anomaly in Neonatal Chylothorax Visualized after Oral Administration of [131I] IHDA.
Eur J Nucl Med Mol Imaging. 2017; 44(Suppl2):S563-S564.-30th Annual Congress of the European Association of Nuclear Medicine; OCT 21-25, 2017; Vienna, AUSTRIA. [Poster]
FullText

 

Decristoforo, C; Kvaternik, H Extemporaneous Preparation of Radiopharmaceuticals
ESRR’16 – 18th European Symposium on Radiopharmacy and Radiopharmaceuticals ; April 07-10, 2016 ; Salzburg, Austria. 2016. [Oral Communication]

 

Kvaternik, H; Hausberger, D; Rumpf, B; Aigner, RM Assay of HEPES in 68Ga-peptides by HPLC
EJNMMI Radiopharmacy and Chemistry . 2016; 2016 1(Suppl 1)(10):PP26--ESRR’16 – 18th European Symposium on Radiopharmacy and Radiopharmaceuticals ; April 07-10, 2016 ; Salzburg, Austria. [Poster]
FullText

 

Kvaternik, H; Hausberger, D; Zink, C; Rumpf, B; Aigner, RM 68Ga-peptide preparation with the use of two 68Ge/68Ga-generators
EJNMMI Radiopharmacy and Chemistry . 2016; 2016 1 (Suppl 1)(10):PP25--ESRR’16 – 18th European Symposium on Radiopharmacy and Radiopharmaceuticals ; April 07-10, 2016 ; Salzburg, Austria. [Poster]
FullText

 

Kvaternik, H; Müller, R; Hausberger, D; Zink, C; Aigner, RM 68Ga- and 177Lu-labelling of PSMA-617
EJNMMI research. 2016; 6 Suppl 1(32):A25--The „Radioactive Isotopes in Molecular Imaging", 32nd International Austrian Winter Symposium; JAN 20-13, 2016; Zell am See Austria. [Poster]

 

Kvaternik,H Radiopharmaceutical Quality Control in Austria: Regulatory Requirements and Setting Up Processes
IAEA Technical Meeting on “New Guidelines on Quality Control of Radiopharmaceuticals” ; May 9-13; Vienna, Austria. 2016. [Oral Communication]

 

Kerschbaumer, S; Hofbauer, L; Kvaternik, H; Gstettner, C; Aigner, RM Comparison of time-of-flight PET-CT results for micro hollow spheres from 31 microliter to 8 milliliter for Fluorine-18, Gallium-68 and Yttrium-90.
EUR J NUCL MED MOL I. 2015; 42: S341-S341.-28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 10-14, 2015; Hamburg, GERMANY. [Poster]
Web of Science

 

Kvaternik, H; Barowitsch, C; Hausberger, D; Kerschbaumer, S; Aigner, RM (68)Ga processing in the preparation of (68)Ga-citrate
EUR J NUCL MED MOL I. 2015; 42: S474-S474.-28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 10-14, 2015; Hamburg, GERMANY. [Poster]
Web of Science

 

Kvaternik, H; Barowitsch, C;Hausberger; D;Müller, R; Aigner; RM Bestimmung von HEPES in Ga-68 markierten Peptiden mittels HPLC
. 2015; -11. OGN Kongress, Österreichische Gesellschaft für Nuklearmedizin & Molekulare Bildgebung; JAN 21-23, 2015; Zell am See, AUSTRIA. [Poster]

 

Kerschbaumer, S; Stücklschweiger; H, Kvaternik, H; Gstettner, C; Guss, H; Aigner, RM. Routine estimation of effective patient dose for SPECT-CT and PET-CT hybride cameras in nuclear medicine diagnostic.
Dreiländertagung der Medizinischen Physik; SEP 7-10, 2014; Zürich, Schweiz. 2014. [Poster]

 

Kvaternik,H; Müller,R; Aigner,RM Improved large scale synthesis of 6-[18F]fluorodopamine (18F-FDA).
Nuklearmedizin. 2014; 52(6):A136--31st Symposium Radioactive Isotopes in Molecular Imaging Abstract; JAN 22-25,2014; Zell am See, AUSTRIA. [Poster]

 

Kvaternik, H; Barowitsch, C; Kerschbaumer, S; Aigner, RM Evaluation of a strip test for rapid visual determination of tin in 99mTc-radiopharmaceticals
EUR J NUCL MED MOL I. 2013; 40: S427-S427.-Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 19-23, 2013; Lyon, FRANCE. [Poster]
Web of Science

 

Kvaternik, H; Müller, R; Aigner, RM Improved Synthesis of 6-[18F]Fluorodopamine (18F-FDA) using Deuterochloroform as Solvent
Proceeding 21. Jahrestagung der Arbeitsgemeinschaft für Radiochemie/Radiopharmazie (AGRR 13). 2013; -21. Jahrestagung der Arbeitsgemeinschaft für Radiochemie/Radiopharmazie (AGRR); SEPT 12-14,2013; Pamhagen, AUSTRIA. [Oral Communication]

 

Kvaternik,H Hybride Imaging: Future Trends in PET Tracer beyond FDG
42nd Meeting of Radiologists of the Alpe-Adria Region; NOV 15-16, 2013; Ljubljana, SLOVENIA. 2013. [Oral Communication]

 

Kvaternik, H; Hammerschmidt, F; Schweifer, A; Wanek, T; Kuntner, C; Müller, R; Aigner, RM Improvement in the synthesis of N.C.A. [131I]mIBG and [124I]mIBG.
Nuklearmedizin (Schattauer GmbH). 2012; 50(6):A157--Radioactive Isotopes in Clinical Medicine and Research; Jan 11-14, 2012; Bad Hofgastein, Austria. [Oral Communication]

 

Kvaternik, H;Denk, C;Wanek, T;Stanek, J;Müller, R;Kuntner, C;Aigner, RM Improved Synthesis of 131I and 124I labelled hyaluronic acid.
Q J Nucl Med. 2012; Suppl 1 to No. 2(56):31--16th European Symposium on Radiopharmacy and Radiopharmaceuticals; APR 26-29, 2012; Nantes, France. [Poster]

 

Kvaternik, H; Hammerschmidt, F; Schweifer, A; Wanek, T Synthesis of carrier added and n.c.a. [124I]mIBG for microPET application
J Label Cpd Radiopharm . 2011; 54(S1):S381--19th International Symposium on Radiopharmaceutical Sciences (ISRS); AUG 28 - SEP 02, 2011; Amsterdam, The Netherlands. [Poster]
Web of Science

 

Wanek, T; Stanek, J; Kuntner, C; Sauberer M; Kvaternik, H;Mueller, M; Zeitlinger, M; Langer, O Small animal PET evaluation of [18F]ciprofloxacin in ABC transporter knockout mice.
Abstracts of the 2011 World Molecular Imaging Congress. 2011; P772--Annual World Molecular Imaging Conference (WMIC 2011); SEP 7-10, 2011; San Diego, California, USA. [Poster]
FullText

 

Dangl, D; Hornof, M; Hoffer, M; Kunter, C; Wanek. T, Kvaternik, H In vivo evaluation of optical residence time of 124I-labelled tholated chitosan in rabbits using micropet technology.
Abstract ARVO Annual Meeting . 2009; -Association for Research in Vision and Opthalmology, ARVO Annual Meeting ; MAY 3-7, 2009; Ft. Lauderdale, Florida, USA. [Poster]
FullText

 

Dimou, E; Widhalm, G; Marosi, C; Roessler, K; Nasel, C; Duan, H; Trifina, E; Hajos, F; Kvaternik, H; Angelberger, P; Dudczak, R; Li. S Imaging of vascular endothelial growth factor receptor (VEGFR) expression of human brain tumors using I-123-VEGF.
Eur J Nucl Med Mol Im. 2009; 39(S2):S275--Annual Congress of the European Association of Nuclear Medicine (EANM); OCT 10-14,2009; Barcelona, Spain. [Oral Communication]

 

Kvaternik, H; Kuntner, C; Wanek, T; Hruby, R; Zolle I Synthesis of 124I-iodometomidate and in vivo kinetics by small-animal PET.
J Nucl Med. 2009; 50(5 S2):324--2009 Annual meeting of the Society of Nuclear Medicine ; JUN 11-14; Toronto, Canada. [Oral Communication]

 

Stundner, G; Wanek, T; Dangl, D; Hornof, M; Kvaternik, H; Langer, O; Kuntner, C Determination of ocular residence times of 124I-labelled eye drop formulations in rabbits with small animal PET.
2009 World Molecular Imaging Congress (WMIC 2009); SEP 23-26, 2009; Montreal, Canada.. 2009. [Poster]

 

Hermann, J; Dunzinger, A; Schaffler, G; Kvaternik, H; Graninger, W; Lipp, RW ANTI-TNF SCINTIGRAPHY AS AN ASSESSMENT TOOL IN RHEUMATOID ARTHRITIS.
Annals of the Rheumatic Diseases [OP-0187]2008; -EULAR Meeting; June 11-14, 2008; Paris. [Oral Communication]

 

Hermann, J; Dunzinger, A; Schaffler, G; Kvaternik, H; Graninger, WB; Lipp, RW; Anti-TNF Scintigraphy as an assessment tool in rheumatoid arthritis.
[OP0187] Ann Rheum Dis2008; 67(3):-EULAR; JUN 11-14, 2008; Paris, FRANCE. [Poster]

 

Hermann, J; Dunzinger, A; Schaffler, G; Kvaternik, H; Lipp, R; Graninger; 99mTC-INFLIXIMAB SZINTIGRAPHIE ZUR BEURTEILUNG DER SPEZIFISCHEN GELENKSENTZÜNDUNG BEI RHEUMATOIDER ARTHRITIS
Journal für Mineralstoffwechsel. 2008; 18(4):188-204.-ÖGR-Herbsttagung; Nov 28-29; Wien. [Poster]

 

Berndt, U; Stanetty, C; Berger, M; Kvaternik, H; Wolf, T; Kuntner, C; Wanek, T; Angelberger, P; Noe, C. Synthesis and Evaluation of [18F]FBTA, a potential Amyloid Imaging Agent.
J Label Cpd Radiopharm . 2007; 50(S1):S87--17th International Symposium on Radiopharmaceutical Sciences (ISRS); APR 30 -MAY 4, 2007; Aachen, Germany. [Keynote lecture]

 

Berndt, U; Stanetty, C; Kuntner, C; Wanek, T; Stanek, J; Berger, M; O. Langer, O; Henriksen, G; Kvaternik, H; Angelberger, P; Noe, C Synthesis and Evaluation of a [18F]Fluorobenzothiazole as Amyloid Imaging Agent.
Nuklearmedizin. 2007; 46(6):A149--Radioactive Isotopes in Clinical Medicine and Research; JAN 09-12, 2008; Bad Hofgastein, Austria. [Oral Communication]

 

Kuntner, C; Bankstahl, J; Abrahim A; Karch, R; Stanek, J; Wanek, T; Zsebedics, M; Wadsak, W; Kletter, K; Löscher W; Kvaternik, Müller M; Langer, O P-gp inhibition at the blood-brain-barrier visualized with (R)-[11C]verapamil µPET
Nuklearmedizin. 2007; 47(6):A161--Radioactive Isotopes in Clinical Medicine and Research; JAN 09-12, 2008; Bad Hofgastein, Austria. [Oral Communication]

 

Langer, O; Bankstahl, J; Kuntner, C; Abrahim A; Karch, R; Stanek, J; Wanek, T; Zsebedics, M; Wadsak, W; Kletter, K; Löscher W; Müller, M; Kvaternik, H In vivo dose finding of tariquidar using (R)-[11C]verapamil µPET.
Nuklearmedizin. 2007; 46(6):A161--Radioactive Isotopes in Clinical Medicine and Research; JAN 09-12, 2008; Bad Hofgastein, Austria. [Oral Communication]

 

Langer, O; Kuntner, C; Wanek, T; Bauer, M; Mandler, M; Angelberger, P; Mueller, M; Kvaternik, H MicroPET Imaging with [18F]FDDNP and [18F]FDG in a Transgenic Mouse Model of Alzheimer’s Disease.
J Label Cpd Radiopharm . 2007; 50(S1):S497--17th International Symposium on Radiopharmaceutical Sciences (ISRS); APR 30 -MAY 4, 2007; Aachen, Germany. [Poster]

 

Kvaternik, H; Kuntner, C; Wanek, T; Angelberger, P; Hruby, R; Zolle, I 123/124I-Iodo-metomidate: Optimized preparation and kinetic studies by micro-PET.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging . 2006; 50(Sup 1):10--13th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESSR 06) ; MAR 30 - APR 3, 2006; Lucca, Italy. [Oral Communication]

 

Langer, O; Kuntner, C; Wanek, T; Bauer, M; Mandler, M; Angelberger, P; Mueller, M; Kvaternik, H MicroPET imaging with the beta-amyloid probe [F-18]FDDNP in a transgenic mouse model of Alzheimer's disease.
Pharmacology. 2006; 78(3):153--12th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; NOV 23-26; Vienna, Austria. [Oral Communication]
Web of Science

 

Kuntner, C; Buchheit, O, Redl, C; Wanek, T; Kvaternik, H; Angelberger, P; Hruby, R; Decristoforo, C; von Guggenberg, E µPET Study of 68Ga-DOTA-Lanreotide for development of targeted therapy of NET with 67Ga-DOTA-Lanreotide.
Nuklearmedizin. 2005; 44(6):-International Symposium “Radioactive Isotopes in Clinical Medicine and Research”; JAN 11-14, 2006; Bad Gastein, Austria. [Oral Communication]

 

Kvaternik, H; Angelberger, P; Stanek, J; Wanek, T; Schmiedl, O Modification of a Nucleophilic Substitution (NS) Module for the radiosynthesis of [18F]Fluoromethylcholine (18F-FCH).
Proceeding of the 12th European Symposium on Radiopharmacy and Radiopharmaceuticals . 2004; -12th European Symposium on Radiopharmacy and Radiopharmaceuticals ; MAR 30 - APR 3, 2004; Gdansk, Poland. [Oral Communication]

 

Aigner, RM; Schultes, G; Kvaternik, H; Angelberger, P; Yamashita, Y; Nicoletti, R; Kaercher, H In-Transferrin in the Detection of Oral Squamous Cell Carcinoma: Preliminary Results
Eur J Nucl Med Mol Im. 2003; 30(S2):S286-S286.-Annual Congress of the European Association of Nuclear Medicine; AUG 23-27, 2003; Amsterdam, NETHERLANDS. [Oral Communication]

 

Kvaternik, H; Angelberger, P; Serro. W; Radiopharmaceutical development of 90Y-Yttrium-Ferric-Hydroxide (YFH) for radiation synovectomy.
Proceeding of the 11th European Symposium on Radiopharmacy and Radiopharmaceuticals. 2003; -11th European Symposium on Radiopharmacy and Radiopharmaceuticals; MAR 15-18, 2003; Innsbruck, Austria. [Oral Communication]

 

Kvaternik, H; Stanek, J; Angelberger P. Development of an automated synthesis of 18F-Fluoromethylcholine (18F-FCH).
Nuklearmedizin. 2003; 42(6):A155--Radioactive Isotopes in Clinical Medicine and Research; JAN 13-16, 2004; Bad Gastein, Austria. [Oral Communication]

 

Schirbel, A; Kvaternik, H; Hammerschmidt, F; Berger, ML; Zolle, I In vivo evaluation of new labelled derivatives of etomidate for adrenal imaging.
J Nucl Med. 2003; 44(5S):154P-155P.-2003 Annual meeting of the Society of Nuclear Medicine ; JUN 21-25; New Orleans, Louisiana, USA. [Oral Communication]
Web of Science

 

Zolle, I; Berger, ML; Hammerschmidt, F; Schirbel, A; Kvaternik, H; Angelberger, P Design, Synthesis and Biological Evaluation of Derivatives of Etomidate as Radiotracers for Imaging of Adrenal Pathology.
Proceeding of the 11th European Symposium on Radiopharmacy and Radiopharmaceuticals . 2003; -11th European Symposium on Radiopharmacy and Radiopharmaceuticals; MAR 15-18, 2003; Innsbruck, Austria. [Oral Communication]

 

Kvaternik, H; Angelberger, P; Buchtela, K Reactor-produced [18F]Fluoride in the synthesis of nca 2-[18F]Fluoro-2-deoxy-glucose
Proceedings of the VIIIth International Symposium on Radiopharmaceutical Chemistry. 1998; -8th International Symposium on Radiopharmaceutical Chemistry; JUL 04-08; 1988; Groningen, Netherlands. [Poster]

 

Angelberger, P; Kvaternik, H; Casta, J Development of 166Ho-Ho, Fe-Hydroxide (HFH) and 166Ho-Hydroxy-Apatite (HA) for Radioembolization Therapy of Liver Malignancies.
Proccedings of the XIIth International Symposium on Radiopharmaceutical Chemistry. 1997; -12th International Symposium on Radiopharmaceutical Chemistry; JUN 15-19, 1997; Uppsala, Sweden. [Poster]

 

Angelberger, P; Brücke, T; Kvaternik, H; Wanek, T Radiopharmaceutical development of 123I-(+)-3-iodo-MK801 for NMDA-receptor scintigraphy.
Eur J Nucl Med. 1996; 23(1):S16--International Symposium “Radioactive Isotopes in Clinical Medicine and Research"; JAN 09-12, 1996; Badgastein; Austria. [Oral Communication]

 

Pirich, C; Flores, J; Wanivenhaus, A; Kritz, H; Prüfert, U; Havlik, E; Kvaternik, H; Angelberger, P; Sinzinger, H Radiation Synovectomy with 165Dy-Ferric Hydroxide, experimental, clinical and dosimetric aspects
Eur J Nucl Med. 1996; 23(1):S14--International Symposium “Radioactive Isotopes in Clinical Medicine and Research"; JAN 09-12, 1996; Badgastein, Austria. [Oral Communication]

 

Angelberger, P; Kvaternik, H; Portner, R; Hammerschmidt, F Optimized preparation of the dopaminergic receptor ligands 123I-Epidepride und 123I-CIT
Radioactive Isotopes in Clinical Medicine and Research, Birkhäuser Verl. Basel . 1995; 281-285.-International Symposium “Radioactive Isotopes in Clinical Medicine and Research" ; JAN 08-12, 1995; Badgastein, Austria. [Oral Communication]

 

Angelberger, P; Virgolini, I; Buchheit, O; Egger, M; Kvaternik, H Radiopharmaceutical development of 123I-Vasoactive Intestinal Peptide (VIP) for receptor scintigraphy in oncology.
Proceeding of the XIth International Symposium on Radiopharmaceutical Chemistry. 1995; -11th International Symposium on Radiopharmaceutical Chemistry; AUG, 13-17, 1995; Vancouver, Canada. [Poster]

 

Kvaternik, H; Angelberger, P; Zeger, H Preparation and quality control of 153Samarium-EDTMP for radio-therapy of metastatic bone pain
Radioactive Isotopes in Clinical Medicine and Research, Birkhäuser Verl. Basel . 1995; 357-360.-International Symposium “Radioactive Isotopes in Clinical Medicine and Research" ; JAN 08-12, 1995; Badgastein, Austria. [Poster]

 

Kvaternik, H. ;Angelberger, P; Sinzinger, H; Nedelik, A; Steger F; Dy-165- Dysprosium-Eisen-Hydroxide: ein neues Radiopharmakon für die nuklearmedizinische Therapie
Radioaktive Isotope in Klinik und Forschung, F.K. Schattauer Verl. Stuttgart . 1993; 274-278.-International Symposium “Radioactive Isotopes in Clinical Medicine and Research" ; JAN 07-10, 1992; Badgastein, Austria. [Oral Communication]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum